Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Neoplasms × Estrogens × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sleep Apnea, Obstructive 1 Polycystic Ovary Syndrome 1 Metabolic Syndrome 1 Insulin Resistance 1 Glucose Intolerance 1 Breast Neoplasms 1

Interventions

Letrozole 17 exemestane 11 Docetaxel 11 Anastrozole 11 Tamoxifen 9 Cyclophosphamide 9 Zoledronic Acid 8 Paclitaxel 8 Capecitabine 8 Trastuzumab 7 Fulvestrant 7 pegfilgrastim 6 Saline Solution 6 liposomal doxorubicin 5 Sodium Chloride 5 Epirubicin 5 Dexmedetomidine 5 Bupivacaine 5 Bevacizumab 5 palbociclib 4 Tranexamic Acid 4 Filgrastim 4 trastuzumab deruxtecan 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 3 ribociclib 3 pertuzumab 3 eribulin 3 abemaciclib 3 Standard of Care 3 Sevoflurane 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05562518 2025-07-23

GRACE

University Hospital, Ghent

Phase 4 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡